Director/PDMR Shareholding

Summary by AI BETAClose X

Standard Life plc announced that Jacqueline Noakes, Group Chief Operating Officer, exercised nil-cost options under the Deferred Bonus Share Scheme on 16 June 2026. She acquired 14,531 ordinary shares and subsequently sold 6,885 shares at 797.18 pence each to cover tax liabilities, retaining 7,646 shares. This transaction relates to the financial year ended 31 December 2022, with vesting subject to a three-year holding period.

Disclaimer*

Standard Life plc
17 June 2026
 

17 June 2026

Standard Life plc (the 'Company')

Exercise of nil-cost options under the Company's Deferred Bonus Share Scheme (the 'DBSS')

The Company was today informed that on 16 June 2026, the following Person Discharging Managerial Responsibilities 'PDMR' exercised their nil-cost options over ordinary shares of 10 pence each in the Company under the DBSS granted on 17 March 2023.

 

Vesting of these options was subject to a three-year holding period in respect of the deferred bonus for the financial year ended 31 December 2022. The number of options acquired include dividend equivalent shares.

 

Name

Title

Number of options exercised

Number of ordinary shares sold to cover Tax and Employee NI

 

Number of ordinary shares held

Sale price per share (in pence)

Jacqueline Noakes

Group Chief Operating Officer

14,531

6,885

7,646

797.18

 

 

Notification and public disclosure of transactions by a person discharging managerial responsibilities

 

The Notification of Dealing Forms for the PDMR can be found below. This announcement is made in accordance with Article 19(3) of the UK Markets Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018). 

 

1

 

Details of the person discharging managerial responsibilities

 

a)

 

Name

 

Jacqueline Noakes

2

 

Reason for the notification

 

a)

 

Position/status

 

Group Chief Operating Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Standard Life plc

b)

 

LEI

 

2138001P49OLAEU33T68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Standard Life plc ordinary shares of 10 pence each

 

 

GB00BGXQNP29

b)

 

Nature of the transaction

 

Acquisition of shares pursuant to the exercise of options for the DBSS Award and sale of shares to cover tax liabilities

c)

 

Price(s) and volume(s)

 

 

 

Item

Price(s) (in pence)

Volume(s)

Exercise of DBSS Options

nil

14,531

Sale of Shares - DBSS

797.18

6,885

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A - single transaction

e)

 

Date of the transaction

16 June 2026

 

f)

Place of the transaction

 London Stock Exchange (XLON)

 

Enquiries:

Media
Shellie Wells, Corporate Communications Director, Standard Life

+44 (0) 204 559 3031

Investors
Claire Hawkins, Director of Corporate Affairs & Brand, Standard Life
+44 (0) 204 559 3161

Tom Blackwell

Managing Director, FTI

+44 (0) 7747 113 919

Joanne Roberts, Investor Relations Director, Standard Life

+44 (0) 204 559 4673



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings